deCODE Homepage - www.decode.com deCODE's Therapeutic Pipeline From Genes to Drugs About deCODE genetics Investors - DCGN deCODE services




January 8, 2007
Study of diabetes risk gene reveals evidence of strong positive natural selection linked to energy metabolism

In a paper published today, scientists from deCODE genetics and colleagues in the US and Europe refine the understanding of the variant in the TCF7L2 gene that deCODE has linked to increased risk of type 2 diabetes (T2D). This variant, which has been widely replicated, appears to confer risk of T2D by decreasing insulin secretion. Intriguingly, in the same study, the authors identify another variant of the same gene that seems to have undergone marked natural selection in East Asia, roughly concurrent with the advent of agriculture. This second variant is associated with increased body mass index (BMI) and altered concentrations of hunger and satiety hormones.

The authors postulate that it may have conferred a significant advantage to those faced by the new environmental challenges of settled agricultural life through its impact on energy metabolism, perhaps also in modern times increasing the propensity for obesity, a major environmental risk factor for T2D. These findings underscore the significance of TCF7L2 not only as one of the best validated risk genes for a common disease but also as a point of intersection between human evolution and disease. The paper, entitled “Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution,” is published online in Nature genetics, at www.nature.com/ng, and will appear in an upcoming print edition of the journal






www.decode.comSitemapContact deCODE geneticsSubscribe to the deCODE mailing listLegal Notice